ATMI Inc

ATMI — Q3 2012 Earnings Presentation

10 slides from ATMI's earnings presentation, Oct 24, 2012

  1. Slide 1: Q3 2012 Earnings Teleconference

    Q3 2012 Earnings Teleconference October 24, 2012

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Statements contained herein that relate to ATMI’s future performance, including, without limitation, statements with respect to ATMI’s anticipated results of operations or level of business for 2012 or any other future period, are forward-looking statements within the safe harb

  3. Slide 3: Q3 2012 Summary

    v vw Q3 2012 Summary Record revenues and net income > SDS Direct performing inline with expectations > Strong demand for single-use LifeSciences equipment > Includes $2.6M of royalty revenue > Benefit from successful completion of advanced materials collaborative development program (CDP) > Operatin

  4. Slide 4: ATMI

    ATMI $M (except per share data) Q32012 32011 Change Q22012 Change Revenue 108.8 95.0 +15% 105.9 3% Gross profit 544 44.1 424% 53.5 42% Gross margin 50% 16% 50% Operating income 20.5 11.8 +73% 16.9 +21% Operating margin 19% 12% 16% Net income 14.4 8.0 +79% 114 +26% EPS $0.44 $0.25 $0.35 > Revenue and

  5. Slide 5: Diverse Revenue Mix

    Diverse Revenue Mix Q3 2012 Revenues by Product Q3 2012 Revenues by Sector mimplant 26% mLogic 40% Cu Matericis 46% = Memory 22% mNOWPak 14% . lifeSciences 10% dia da Other 4% wLifeSciences 10% Q3 2012 Revenues by Geography Implant growth from SDS transaction wASia 69% LifeSciences equipment sales g

  6. Slide 6: Microelectronics

    Microelectronics Q3 2012 Q32011 Change Q2 2012 Revenue 98.4 85.8 +15% 94.6 +4% Gross margin 52% 48% 52% Operating income 34.0 24.3 441% 30.5 +13% Operating margin 35% 28% 32% > SDS Direct delivered $7.4M of revenues and $0.10 of diluted EPS in the quarter > Operating margin improved due to royalty r

  7. Slide 7: LifeSciences

    LifeSciences Q3 2012 Q32011 Change Q22012 Change Revenue 104 9.2 +13% 11.2 1% Gross margin 28% 30% 38% Operating (loss) (2.1) (2.2) (1.4) Operating margin (21%) (24%) (10%) > Q3 down sequentially due to European seasonality; up Y/Y on increased equipment sales > Growth in single-use technology is ac

  8. Slide 8: Other Financial Data

    Other Financial Data Q2 2012 Q3 2012 Q3 2011 Cash and marketable securities 139.3 186.2 Cash from operating activities 20.9 24.1 Capital Expenditures 5.2 5.1 Depreciation & Amortization 6.9 6.7 Headcount 825 802 129.3 22.6 7.9 6.8 822 > Rebuilding cash balance following SDS Direct in Q4 2011 > Capex

  9. Slide 9: Outlook

    Vv v v Outlook Microelectronics > Declining wafer starts in Q4 > Reduced R&D spending in 2013 due to efficiencies gained through HPD and elimination of Japan development capacity LifeSciences > Strong growth from seasonally-soft Q3 > Long-term 20-30% CAGR Long-term growth outlook favorable > Growth

  10. Slide 10: Thank you for your interest

    @O ATM! Thank you for your interest. Troy Dewar Director, Investor Relations 208.207.9349 tdewcr@ctmicom

Atmi — Q3 2012 Earnings Presentation on 6ix